United Kingdom· GB-APID-763311000001109
Levobunolol 0.5% eye drops
A levobunolol product containing levobunolol, registered in United Kingdom by Teva UK Ltd. The same ATC class is registered in 8 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Levobunolol is registered in 8 of 19 countries.
Countries holding a registration under ATC S01ED03 (levobunolol), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 4 of them publish a price we can compare per daily dose
Levobunolol · ATC S01ED03
8 / 19 countries
- Finlandprice
- Franceprice
- Germany
- Ireland
- Japan
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Levobunolol
- Manufacturer
- Teva UK Ltd
- Country
- United Kingdom (GB)
- ATC code
- S01ED03
- ATC class
- Levobunolol
- Defined daily dose
- 0.2 ml, AT
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5016192538318
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
127 interactions on record for levobunolol.
Graded by severity as the source publishes them — 26 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Levobunolol · interactions on record
127 records
- 26 severe
- 68 moderate
- 2 minor
- 31 info
Most severe, free to view
- EpinephrineB02BC09severe
- EpinephrineC01CA24severe
- OrciprenalinC01CA29severe
- TheophyllinC01EB28severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Levobunolol in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- GermanyVistagan Liquifilm O.K.Abbvie Deutschland Gmbh & Co. Kg
- FinlandBetaganAllergan Limited
- FranceBETAGAN 0,5 % , collyre en solution en récipient unidoseABBVIE
- IrelandBetagan 0.5% w/v Unit Dose Eye Drops, SolutionAbbVie Limited
- ItalyVISTAGAN*collirio 60 flaconcini monodose 0,4 ml 5 mg/mlABBVIE Srl
- BelgiumBetagan 0.5 %Allergan Pharmaceuticals Ireland
- United StatesLevobunolol HydrochlorideBausch & Lomb Incorporated
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- France · Betagan
- Italy · Vistagan
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/33175478-9f38-4284-8d63-04477920d8f9 GET /v1/drugs/33175478-9f38-4284-8d63-04477920d8f9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "763311000001109",
"desc": "Levobunolol 0.5% eye drops (Teva UK Ltd)",
"form": "Eye drops",
"vpid": "42192311000001109",
"source": "dmd",
"vtm_id": "776510007",
"strength": "5 mg",
"substance": "Levobunolol",
"ingredient": "Levobunolol hydrochloride",
"supplier_code": "3849901000001105"
}See everything about levobunolol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.